Efficacy of single-dose and conventional amoxicillin therapy in urinary-tract infection localized by the antibody-coated bacteria technic.
about
Emergency medicine-important advances in clinical medicine: single-dose treatment of urinary tract infectionsRecent developments in the diagnosis and treatment of urinary tract infectionsUrinary tract infectionTrial of three-day and ten-day courses of amoxycillin in otitis mediaUrinary tract infection: significance and management.Randomized clinical trial of rifampin-trimethoprim and sulfamethoxazole-trimethoprim in the treatment of localized urinary tract infections.Treatment duration for urinary tract infections in adults.Single-dose ciprofloxacin at 100 versus 250 mg for treatment of uncomplicated urinary tract infections in womenComparison of single-dose tetracycline hydrochloride to conventional therapy of urinary tract infections.Single-dose cefonicid therapy for urinary tract infections.Single-dose amoxicillin therapy of acute uncomplicated urinary tract infections in women.Urinary tract infections: 1982--use of new concepts to guide therapy.Correlation between uropathogenic properties of Escherichia coli from urinary tract infections and the antibody-coated bacteria test and comparison with faecal strains.Single-dose antibiotic treatment: a new approach to lower urinary tract infections in primary care.Single tablet treatment of urinary tract infections in women.Comparison of single-dose administration and three-day course of amoxicillin with those of clavulanic acid for treatment of uncomplicated urinary tract infection in womenShort- and long-term cure rates of short-duration trimethoprim-sulfamethoxazole treatment in female dogs with uncomplicated bacterial cystitisEffect of indomethacin on the incidence of experimental Escherichia coli pyelonephritisRapid isolation and presumptive diagnosis of uropathogens by using membrane filtration and differential media.Enzyme immunoassay for detection of antibody-coated bacteria.Clinical management of urinary tract infection.Urinary tract infections. 2. Therapeutic approach.Cost-effective antibiotic prescribing.A new citrated formulation of nalidixic acid (Mictral U.K.) for the treatment of acute cystitis.Problem areas in the management of urinary tract infections.The role of bacterial surface structures in pathogenesis.Effect of vancomycin hydrochloride on Staphylococcus epidermidis biofilm associated with silicone elastomer.Sublethal concentrations of antibiotics, effects on bacteria and the immune system.The inhibitory quotient.Ampicillin and alternatives.Treatment of urinary tract infection with a single dose of trimethoprim-sulfamethoxazole.Nalidixic acid and trimethoprim/sulphamethoxazole as alternatives for short-term treatment of urinary infections.Urinary tract infections treated with single dose of short-acting sulphonamide.Single- and multiple-dose pharmacokinetics and tolerability of limaprost in healthy Chinese subjects.
P2860
Q33580288-F950A44D-20A8-4239-A0DE-56F093C27F5EQ34112275-6D9F6B87-1543-49DC-839A-C99E59115279Q34450119-A6B5A939-592E-45E5-BE74-A2F842630D40Q34758173-AD856531-60DC-444C-A8EB-CEBF99352FFFQ35119088-31A92EB5-31E0-4238-BFAA-B22285DCC994Q35308013-6057FBBD-85F2-4714-95CF-5C691D24BFEDQ35535312-FC263621-3D12-40EA-A35E-9AB28B4861E3Q35537357-632A3F8E-D294-43B2-B958-5E9D54C60DC9Q35643233-8A8B6080-7447-486A-B759-AA8954238762Q35744775-FD4BE3AB-AF2D-426F-B8BC-CB4E8773AD86Q35760012-779C7B7C-BD12-45EC-ADC0-42915F2FF095Q35876489-452D9F80-038F-4A69-8070-FF372891450BQ36258050-B1195335-6831-4B36-BC9C-154B003CAF17Q36552170-3C30C5A7-2910-4C45-AD9A-472420B7ADF5Q36576798-73D7A738-35EB-4157-9690-2B49D85819A3Q36754673-C40D4C45-26AC-469A-BB65-BA2470A794C8Q36975045-B0A1C2E6-C8DC-4778-9A00-65B5C5363AB2Q37111750-7230DCEF-D5F5-40DD-A525-3AD5B879288EQ37244276-41D4BEB4-3BD1-4E95-B82F-671CD25E2E6AQ37331562-8174E37C-8104-4348-A564-BA4FFC3D04B7Q37908293-024F268F-80AE-4D35-9963-A47610BF3A61Q37908836-265B1C74-DFD8-4702-BEFB-F2D2149E6296Q38583371-80EAD8FF-09F0-4749-B761-D69CD63D0223Q39569376-3FB34F10-814D-4B5A-9FBC-820EBD5D8ECBQ39686535-9EB919DE-C634-46CE-AC26-B5A54A2C0F74Q40085014-8517076F-8E8C-4FF0-9FB9-0A696AFC33E5Q40283790-5A96DDDB-6D63-476A-A879-7948F76F1B39Q40329789-991CF6BD-2D7A-4C91-8CF5-6A4DD773AD23Q42671234-2FCA4A0C-5768-4900-9A5E-CA1D511A7A2FQ42754713-A847107E-DEBB-490C-90D7-2E4B3E45A8D3Q42928305-3EEE49B1-31FF-490F-93F6-23A78854BDA8Q43503576-D515745C-8E12-4EC0-AC95-E7DFFB50022CQ49327590-1D578020-A739-468F-9B53-F54971330BB4Q51063973-C1B2A860-312E-4BB3-B076-8050DBF59D9B
P2860
Efficacy of single-dose and conventional amoxicillin therapy in urinary-tract infection localized by the antibody-coated bacteria technic.
description
1978 nî lūn-bûn
@nan
1978年の論文
@ja
1978年学术文章
@wuu
1978年学术文章
@zh-cn
1978年学术文章
@zh-hans
1978年学术文章
@zh-my
1978年学术文章
@zh-sg
1978年學術文章
@yue
1978年學術文章
@zh
1978年學術文章
@zh-hant
name
Efficacy of single-dose and co ...... ibody-coated bacteria technic.
@en
type
label
Efficacy of single-dose and co ...... ibody-coated bacteria technic.
@en
prefLabel
Efficacy of single-dose and co ...... ibody-coated bacteria technic.
@en
P2093
P1476
Efficacy of single-dose and co ...... ibody-coated bacteria technic.
@en
P2093
Tolkoff-Rubin NE
P304
P356
10.1056/NEJM197802232980802
P407
P577
1978-02-01T00:00:00Z